![Gilmore O’Neill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gilmore O’Neill
Directeur Général chez
EDITAS MEDICINE, INC.
Fortune : 859 163 $ au 31/05/2026
Profil
Gilmore ONeill occupe le poste de Chief Medical Officer & Executive Vice President chez Sarepta Therapeutics, Inc. Le Dr ONeill est également membre du conseil d'administration du Massachusetts Biotechnology Council et de Unity Biotechnology, Inc. et membre de l'American Academy of Neurology. Dans sa carrière antérieure, il a occupé le poste de vice-président principal chez Biogen, Inc. Gilmore ONeill a obtenu un diplôme de premier cycle à l'University College de Dublin et un diplôme d'études supérieures à l'Université de Harvard.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/06/2026 | 248 313 ( 0,16% ) | 859 163 $ | 31/05/2026 |
Postes actifs de Gilmore O’Neill
| Sociétés | Poste | Début |
|---|---|---|
| EDITAS MEDICINE, INC. | Directeur Général | 01/06/2022 |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Corporate Officer/Principal | - |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Directeur/Membre du Conseil | - |
Anciens postes connus de Gilmore O’Neill
| Sociétés | Poste | Fin |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | 27/06/2025 |
| APTINYX | Directeur/Membre du Conseil | 14/04/2023 |
| SAREPTA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 17/11/2021 |
| BIOGEN INC. | Directeur Technique/Scientifique/R&D | 01/06/2018 |
| APTINYX | Directeur/Membre du Conseil | - |
Formation de Gilmore O’Neill
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Dublin
 University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Commercial Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Aptinyx, Inc.
 Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
